Coleman, Sulamunn R. M. http://orcid.org/0000-0002-0460-4632
Piper, Megan E. http://orcid.org/0000-0002-9876-5460
Byron, M. Justin http://orcid.org/0000-0003-1162-9907
Bold, Krysten W. http://orcid.org/0000-0002-8012-6118
Funding for this research was provided by:
National Institute on Drug Abuse (U54DA036114, U54DA036151, K12DA000167)
U.S. Food and Drug Administration (U54DA036114, U54DA036151)
National Cancer Institute (R01CA239309, K01CA253234-01)
Center for Tobacco Products (K01CA253234-01)
Article History
Accepted: 4 October 2022
First Online: 17 October 2022
Compliance with Ethical Standards
: The Section Editors for the topical collection Tobacco are Grace Kong and Krysten Bold. Please note that Dr. Bold was not involved in the editorial process of this article as she is a co-author.
: Research reported in this publication was supported by National Institute on Drug Abuse (NIDA) and Food and Drug Administration (FDA) Tobacco Centers of Regulatory Science (TCORS) Award U54DA036114 (SRMC) U54DA036151 (KWB), National Cancer Institute (NCI) R01CA239309 (MEP), NCI and FDA Center for Tobacco Products (CTP) grant number K01CA253234-01 (MJB), and NIDA K12DA000167 (KWB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA. The authors have no conflicts of interest to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.